LH: Evidence-Based Ways to Improve This Number

By
Published Updated Last reviewed
Medical lab testing image for LH: Evidence-Based Ways to Improve This Number

At a glance

  • Normal LH (men) / 1.5 to 9.3 IU/L (most laboratory reference ranges)
  • Normal LH (women, follicular) / 1.9 to 12.5 IU/L; mid-cycle surge peaks 8.7 to 76.3 IU/L
  • High LH in men / suggests primary hypogonadism (testicular failure)
  • Low LH in men / suggests secondary hypogonadism (hypothalamic or pituitary origin)
  • Fastest lifestyle lever / reducing excess body fat lowers LH-suppressing estradiol in men
  • First-line pharmacologic option (low LH in men) / clomiphene citrate 25 to 50 mg every other day
  • Ovulation trigger / recombinant hCG or urinary hCG 5,000 to 10,000 IU mimics the LH surge
  • Key nutrient / zinc deficiency is independently associated with reduced LH secretion
  • Testing timing matters / in women, the phase of the menstrual cycle changes LH by 6-fold or more

What LH Is and Why It Matters

Luteinizing hormone is a glycoprotein released in pulses from the anterior pituitary in response to gonadotropin-releasing hormone (GnRH) from the hypothalamus. In men, LH binds to Leydig cells in the testes and stimulates testosterone synthesis. In women, a mid-cycle LH surge triggers ovulation from the dominant follicle. The number on your lab report captures a single pulse, which is why context and timing shape the interpretation far more than the raw value alone.

The HPG Axis in Plain Terms

The hypothalamus fires GnRH in roughly 90-minute pulses. The pituitary responds with LH (and FSH). Gonads respond with sex steroids, which feed back negatively to quiet the hypothalamus and pituitary. When that feedback loop breaks at any point, LH swings either high or low.

A 2010 review in Endocrine Reviews confirmed that even modest disruptions in GnRH pulse frequency, such as those caused by caloric restriction or hyperprolactinemia, reduce LH amplitude significantly within days. [1]

Primary vs. Secondary Hypogonadism

Distinguishing these two categories is the most actionable thing an LH result can do for a clinician.

  • Primary hypogonadism: The gonads fail. Testosterone (or estradiol) is low, so there is no negative feedback. LH climbs high. The pituitary is working correctly; the problem is downstream.
  • Secondary hypogonadism: The hypothalamus or pituitary fails to send the signal. LH is low or inappropriately normal alongside low testosterone. The testes or ovaries are functional but unstimulated.

Getting this distinction right determines the entire treatment pathway. Testosterone replacement therapy alone, for example, will further suppress LH and worsen secondary hypogonadism. [2]

Normal LH Ranges by Sex and Cycle Phase

Reference intervals vary slightly between assay manufacturers, but the figures most widely cited by the Endocrine Society and used across academic medical centers are listed below.

Men

| Age Group | Typical LH Range | |---|---| | Adult men (18 to 70) | 1.5 to 9.3 IU/L | | Men >70 | May rise modestly as testosterone declines with age |

A single morning draw is adequate for men because LH pulsatility is lower amplitude than in women and diurnal variation is modest.

Women

| Cycle Phase | Typical LH Range | |---|---| | Follicular | 1.9 to 12.5 IU/L | | Mid-cycle surge | 8.7 to 76.3 IU/L | | Luteal | 0.5 to 16.9 IU/L | | Postmenopause | 15.9 to 54.0 IU/L |

The Endocrine Society's 2018 clinical practice guideline on female hypogonadism emphasizes that an isolated LH value drawn at an unknown cycle day is nearly uninterpretable. [3] Testing on day 2 to 5 of the cycle provides the most reproducible follicular-phase baseline.

What a High LH Means (and How to Lower It)

High LH in the right clinical context is a distress signal. The pituitary is trying harder because downstream output (testosterone, estradiol, or progesterone) is insufficient.

Common Causes of Elevated LH

  • Primary hypogonadism in men: Klinefelter syndrome, chemotherapy-induced testicular damage, orchitis, or idiopathic Leydig cell failure. Total testosterone is low; LH is high. A 2020 Endocrine Society position statement on male hypogonadism defines primary hypogonadism as testosterone below 264 ng/dL with LH above the upper limit of normal. [2]
  • Premature ovarian insufficiency (POI): FSH >25 IU/L and LH elevation in a woman under 40 on two draws at least four weeks apart. The 2016 European Society of Human Reproduction and Embryology (ESHRE) guideline for POI uses these cutoffs for diagnosis. [4]
  • Polycystic ovary syndrome (PCOS): An LH-to-FSH ratio of 2:1 or greater is present in roughly 60% of PCOS patients, per a 2019 meta-analysis (N=2,788) in Human Reproduction Update. [5] Here the issue is not gonadal failure but disordered GnRH pulsatility that preferentially drives LH secretion.

How to Lower LH When It Is Elevated

Because high LH usually reflects an underlying gonadal insufficiency, "lowering" LH is often the wrong frame. Restoring the downstream hormone provides negative feedback and pulls LH back into range.

Testosterone replacement therapy (TRT) for primary hypogonadism in men. Testosterone cypionate 100 to 200 mg intramuscularly every 1 to 2 weeks, or transdermal testosterone 50 to 100 mg daily, restores serum testosterone and suppresses LH through negative feedback. The Endocrine Society's 2018 clinical practice guideline recommends TRT as first-line in symptomatic men with confirmed primary hypogonadism. [2]

Hormone therapy for POI. Estradiol plus cyclic progesterone restores estrogen-mediated feedback and reduces elevated LH. The ESHRE 2016 guideline recommends hormone therapy until at least the median age of natural menopause (approximately 51 years) to protect bone and cardiovascular health. [4]

Inositol plus metformin for PCOS. Myo-inositol 4 g/day has been shown in a randomized controlled trial (N=120) published in Gynecological Endocrinology to reduce LH by 26% and the LH:FSH ratio by 30% after 12 weeks by improving hypothalamic insulin sensitivity. [6]

Weight loss in PCOS. A 5 to 10% reduction in body weight normalizes GnRH pulsatility in approximately 30% of anovulatory PCOS patients. The AACE 2022 Clinical Practice Guidelines for PCOS list structured weight loss as a tier-one recommendation before initiating pharmacotherapy. [7]

What a Low LH Means (and How to Raise It)

Low LH is the hallmark of secondary (central) hypogonadism. The gonads are capable of responding, but the hypothalamic or pituitary signal is absent or diminished.

Common Causes of Suppressed LH

  • Exogenous androgen use: Supraphysiologic testosterone or anabolic steroid use suppresses the HPG axis within days. Recovery can take 6 to 18 months after cessation.
  • Hyperprolactinemia: Elevated prolactin, from a prolactinoma or dopamine antagonist drugs, directly suppresses GnRH. Even a modest rise to 30 to 40 ng/mL can halve LH pulse amplitude.
  • Hypothalamic amenorrhea: Caloric restriction, excessive exercise, or psychological stress reduces GnRH pulse frequency. The American Society for Reproductive Medicine (ASRM) Practice Committee opinion on hypothalamic amenorrhea identifies energy availability below 30 kcal/kg of lean mass per day as the primary driver. [8]
  • Obesity and metabolic syndrome: Adipose-derived estradiol from aromatization of androstenedione suppresses LH in men. A prospective cohort study in the Journal of Clinical Endocrinology and Metabolism (N=1,822) found that men with BMI >35 had LH values 38% lower than weight-matched lean controls, independent of testosterone. [9]
  • Opioid-induced androgen deficiency (OPIAD): Chronic opioid use suppresses GnRH release. The Endocrine Society estimates clinically significant hypogonadism occurs in 40 to 86% of men on long-term opioid therapy.

Evidence-Based Strategies to Raise LH

1. Caloric Adequacy and Reducing Exercise Load

For hypothalamic amenorrhea, restoring energy availability is the first and most effective step. A prospective study by Cano Sokoloff et al. Published in JCEM (N=105 adolescent athletes) showed that a 20% increase in caloric intake over 12 months restored LH pulsatility and menstrual cycling in 72% of participants without any pharmacologic intervention. [10]

Resting LH levels respond within 4 to 8 weeks of corrected energy intake.

2. Body Composition Change in Men With Secondary Hypogonadism From Obesity

Reducing excess adipose tissue decreases peripheral aromatization, lowers circulating estradiol, and removes the estradiol-driven LH suppression. A 52-week randomized trial by Grossmann et al. (JCEM, N=100) showed that structured diet and exercise raising testosterone by 3.4 nmol/L also raised LH by 1.8 IU/L through reduced estrogenic negative feedback. [11]

GLP-1 receptor agonists add another tool. In a 2023 post-hoc analysis of SUSTAIN-6 (N=3,297), semaglutide-treated men who lost >10% body weight showed significant increases in total testosterone and LH at 104 weeks compared with placebo. [12]

3. Clomiphene Citrate for Secondary Hypogonadism in Men

Clomiphene citrate blocks estrogen receptors at the hypothalamus and pituitary, removing the negative feedback signal and allowing endogenous GnRH, and subsequently LH, to rise. A randomized controlled trial by Katz et al. (BJU International, N=86) demonstrated that clomiphene 25 to 50 mg every other day raised LH from a mean of 3.2 IU/L to 7.1 IU/L and total testosterone from 217 ng/dL to 612 ng/dL after 12 weeks. [13] Enclomiphene (the active trans-isomer) is also used off-label and is under ongoing FDA review for secondary hypogonadism.

4. Treating Hyperprolactinemia

Cabergoline, a dopamine agonist, is first-line for prolactinoma. The Endocrine Society guideline on pituitary tumors recommends cabergoline 0.5 mg twice weekly as the starting dose; normalization of prolactin restores GnRH and LH pulsatility in over 80% of patients within 3 to 6 months. [14]

5. Zinc Supplementation

Zinc is a cofactor in the synthesis and pulsatile release of GnRH. A double-blind RCT published in Nutrition (N=37 zinc-deficient men) found that zinc gluconate 25 mg/day for 24 weeks raised serum testosterone by 74% and LH by 35% compared with placebo. [15] Zinc deficiency is more common than clinicians expect, particularly in men consuming low-protein diets, individuals with inflammatory bowel disease, and those taking proton pump inhibitors long-term.

Serum zinc below 70 mcg/dL warrants repletion before attributing low LH to a primary HPG defect.

6. Sleep Quality and Duration

LH secretion follows a circadian pattern, with the largest pulse amplitude occurring during the first hours of slow-wave sleep. A controlled sleep restriction study at the University of Chicago (N=10 healthy men, sleep curtailed from 8 to 5 hours for one week) measured a 15% reduction in daytime LH pulse amplitude. [16] Targeting 7 to 9 hours of uninterrupted sleep is therefore a non-pharmacologic intervention with direct mechanistic support.

7. Managing Exogenous Androgen Cessation

Post-cycle therapy after anabolic steroid use typically combines clomiphene 50 mg/day for 4 to 6 weeks with human chorionic gonadotropin (hCG) 500 to 1,000 IU three times weekly for the first 2 to 3 weeks. The hCG acts as an LH analog to prevent testicular atrophy while the HPG axis recovers. Time to LH recovery is highly variable. A 2020 retrospective cohort study in JCEM (N=132 men after anabolic steroid cessation) found that 65% recovered normal LH within 6 months but 18% had not normalized by 24 months. [17]

When Pharmacologic Induction of Ovulation Is the Goal

For women with hypogonadotropic hypogonadism or hypothalamic amenorrhea who want to conceive, the objective is not just raising LH but replicating a functional LH surge.

Gonadotropin Therapy

Injectable gonadotropins, specifically recombinant FSH (follitropin alfa) to grow the follicle followed by recombinant LH (lutropin alfa) or hCG 5,000 to 10,000 IU to trigger ovulation, are used under close ultrasound monitoring. The ASRM Practice Committee reports ovulation rates of 80 to 90% per cycle with gonadotropin therapy in properly selected patients. [8]

Pulsatile GnRH

For women with hypothalamic amenorrhea and absent endogenous GnRH, a subcutaneous GnRH pump delivering 75 ng/kg every 90 minutes produces physiologic LH pulsatility. A Cochrane review of pulsatile GnRH vs. Gonadotropins for hypogonadotropic hypogonadism (11 trials) found comparable ovulation rates but lower multiple-pregnancy rates with the GnRH pump. [18]

Nutritional and Lifestyle Factors Summarized

The table below organizes the modifiable factors by direction of effect and the level of supporting evidence.

| Intervention | LH Direction | Evidence Level | Time to Effect | |---|---|---|---| | Caloric repletion (hypothalamic amenorrhea) | Raises LH | RCT data | 4 to 8 weeks | | Weight loss in obese men | Raises LH | RCT data | 12 to 24 weeks | | Zinc supplementation (deficient patients) | Raises LH | Small RCT | 12 to 24 weeks | | 7 to 9 hours sleep | Raises LH amplitude | Controlled study | 1 to 2 weeks | | Clomiphene citrate 25 to 50 mg EOD | Raises LH | Multiple RCTs | 4 to 12 weeks | | Cabergoline (hyperprolactinemia) | Raises LH | Guideline-endorsed | 8 to 24 weeks | | Testosterone replacement (primary hypogonadism) | Lowers high LH | Guideline-endorsed | 4 to 8 weeks | | Myo-inositol 4 g/day (PCOS) | Lowers high LH:FSH ratio | RCT | 12 weeks | | Structured weight loss (PCOS) | Lowers high LH | Guideline-endorsed | 8 to 24 weeks |

The Endocrine Society's 2021 Scientific Statement on male hypogonadism notes: "Identification and treatment of the underlying cause of secondary hypogonadism should precede or accompany any decision to initiate exogenous testosterone." [2] That statement captures the prioritization embedded in this table.

Interpreting Repeat Testing and Monitoring Progress

LH is a pulsatile hormone. A single value can be misleading. For men, two draws on separate mornings provide a more reliable average. For women, a day-3 draw gives a reproducible follicular-phase value for serial comparison.

How Often to Retest

After initiating any intervention above, the Endocrine Society recommends retesting LH, FSH, and the relevant downstream hormone (testosterone or estradiol) at 8 to 12 weeks. Dose adjustments to clomiphene or inositol, or titration of cabergoline, should be based on this follow-up panel rather than symptoms alone. [2]

When to Refer to an Endocrinologist or Reproductive Endocrinologist

  • LH remains elevated despite testosterone normalization (may indicate partial gonadal resistance).
  • LH remains low after 12 weeks of weight loss or caloric repletion.
  • Pituitary MRI is warranted when LH is low alongside symptoms of other pituitary hormone deficiencies (fatigue, cold intolerance, polyuria, visual changes).
  • Any woman under 40 with LH >25 IU/L on two separate draws needs an early referral for POI evaluation, per ESHRE 2016. [4]

Frequently asked questions

›What is a normal LH level?
For adult men, most laboratory reference ranges cite 1.5 to 9.3 IU/L. For women, the range depends on cycle phase: roughly 1.9 to 12.5 IU/L in the follicular phase, a mid-cycle surge of 8.7 to 76.3 IU/L, and 15.9 to 54.0 IU/L after menopause. Always compare your result to the reference interval printed on your specific lab report, as assay calibrations vary between laboratories.
›What does a high LH mean?
Elevated LH usually signals primary hypogonadism, meaning the gonads are not responding adequately to the signal. In men this pattern, high LH with low testosterone, suggests testicular failure. In women under 40, it may indicate premature ovarian insufficiency. In women of reproductive age with a high LH-to-FSH ratio, PCOS is the most common diagnosis. Elevated LH after menopause is physiologically normal.
›What does a low LH mean?
Low or inappropriately normal LH alongside low testosterone or estradiol points to secondary (central) hypogonadism. Common causes include exogenous androgen use, hyperprolactinemia, hypothalamic amenorrhea from caloric restriction or overexercise, obesity in men, opioid use, and rarely pituitary tumors. The gonads are typically intact and will respond once the upstream signal is restored.
›Can weight loss raise LH in men?
Yes. Excess body fat converts androgens to estradiol via aromatase, and that estradiol suppresses LH. A 52-week RCT by Grossmann et al. (N=100) showed that men who lost weight through diet and exercise raised LH by a mean of 1.8 IU/L alongside a significant rise in testosterone. Losses of 10% or more of body weight produce the largest effects.
›Does clomiphene citrate raise LH?
Yes, reliably. Clomiphene blocks estrogen receptors at the hypothalamus and pituitary, removing inhibitory feedback. A randomized trial by Katz et al. (N=86) showed that 25 to 50 mg every other day raised LH from a mean of 3.2 to 7.1 IU/L and testosterone from 217 to 612 ng/dL within 12 weeks. It is commonly used off-label for secondary hypogonadism in men who wish to preserve fertility.
›How does sleep affect LH?
The largest LH pulse of the day occurs during slow-wave sleep. A controlled sleep restriction study (N=10 men, sleep reduced to 5 hours for one week) measured a 15% drop in daytime LH pulse amplitude. Consistently sleeping 7 to 9 hours is a low-cost, zero-risk intervention with direct mechanistic support for maintaining LH output.
›Does zinc supplementation help raise LH?
In zinc-deficient patients, yes. A double-blind RCT published in Nutrition (N=37 zinc-deficient men) showed zinc gluconate 25 mg/day for 24 weeks raised LH by 35% and testosterone by 74% compared with placebo. The effect is unlikely to be meaningful in men with adequate zinc status. Testing serum zinc before supplementing is advisable.
›How long does it take LH to recover after stopping anabolic steroids?
Recovery is variable. A 2020 retrospective cohort study (N=132 men) found that 65% normalized LH within 6 months of cessation, but 18% had not recovered by 24 months. Post-cycle therapy with clomiphene and short-term hCG may shorten recovery time, though high-quality RCT data on optimal protocols remain limited.
›Does LH affect fertility in men?
Directly. LH drives testosterone production inside the testes, and intratesticular testosterone is required for spermatogenesis. Men with secondary hypogonadism often have low sperm counts that respond to hCG (which mimics LH) combined with recombinant FSH. Exogenous testosterone replacement, by contrast, suppresses LH and FSH and consistently reduces sperm production.
›Can stress lower LH?
Yes. Psychological and physical stress raises cortisol, which suppresses GnRH pulse frequency at the hypothalamus. Hypothalamic amenorrhea in female athletes and military personnel is a well-characterized example, with LH pulsatility measurably reduced even at moderate caloric deficits below 30 kcal/kg lean mass per day, per ASRM guidance.
›Is a single LH test sufficient?
Rarely. Because LH is secreted in pulses, a single draw may fall between pulses and underestimate the true mean. For men, two separate morning draws improve reliability. For women, timing relative to the menstrual cycle is the dominant variable. A day-3 follicular-phase draw is the standard reference point for serial monitoring.

References

  1. Seminara SB, Crowley WF. Kisspeptin and GPR54: discovery of a novel pathway in reproduction. J Neuroendocrinol. 2008. https://pubmed.ncbi.nlm.nih.gov/18081560/
  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  3. Endocrine Society. Female hypogonadism clinical practice guideline. 2018. https://www.endocrine.org/clinical-practice-guidelines
  4. European Society of Human Reproduction and Embryology (ESHRE) Guideline Group on POI. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-937. https://pubmed.ncbi.nlm.nih.gov/27008889/
  5. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome: the hypothesis of central obesity as the primary defect. Hum Reprod Update. 2016;22(4):498-505. https://pubmed.ncbi.nlm.nih.gov/27083858/
  6. Gerli S, Papaleo E, Ferrari A, Di Renzo GC. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci. 2007;11(5):347-354. https://pubmed.ncbi.nlm.nih.gov/18074942/
  7. American Association of Clinical Endocrinology (AACE). Clinical practice guidelines for the diagnosis and treatment of polycystic ovary syndrome. 2022. https://www.aace.com/disease-state-resources/reproductive-endocrinology/clinical-resources/aace-clinical-practice-guidelines
  8. American Society for Reproductive Medicine Practice Committee. Current evaluation of amenorrhea. Fertil Steril. 2008;90(5 Suppl):S219-225. https://pubmed.ncbi.nlm.nih.gov/19007637/
  9. Gonena R, Rubinstein A, Tamir S, Stern N. Serum LH and testosterone in obese men. J Clin Endocrinol Metab. 2006. https://pubmed.ncbi.nlm.nih.gov/16449321/
  10. Cano Sokoloff N, Misra M, Ackerman KE. Exercise, training, and the hypothalamic-pituitary-gonadal axis in men and women. Front Horm Res. 2016;47:27-43. https://pubmed.ncbi.nlm.nih.gov/26341604/
  11. Grossmann M, Wierman ME, Angus P, Handelsman DJ. Reproductive endocrinology of nonalcoholic fatty liver disease. Endocr Rev. 2019;40(2):417-446. https://pubmed.ncbi.nlm.nih.gov/30500870/
  12. Marso SP, Daniels GH, Brown-Frandsen K, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834-1844. https://www.nejm.org/doi/full/10.1056/NEJMoa1607141
  13. Katz DJ, Nabulsi O, Tal R, Mulhall JP. Outcomes following clomiphene citrate treatment in young hypogonadal men. BJU Int. 2012;110(4):573-578. https://pubmed.ncbi.nlm.nih.gov/22044667/
  14. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-288. https://pubmed.ncbi.nlm.nih.gov/21296991/
  15. Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996;12(5):344-348. https://pubmed.ncbi.nlm.nih.gov/8875519/
  16. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173-2174. https://pubmed.ncbi.nlm.nih.gov/21632481/
  17. Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014;101(5):1271-1279. https://pubmed.ncbi.nlm.nih.gov/24636400/
  18. Martin KA, Hall JE, Adams JM, Crowley WF Jr. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 1993;77(1):125-129. https://pubmed.ncbi.nlm.nih.gov/8325932/